BIOGEN INC (BIIB)       289.1  -3.05 (-1.04%)

289.1  -3.05 (-1.04%)

US09062X1037 - Common Stock - After market: 289.1 0 (0%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
10.36B10.98B13.45B14.38B13.45B
Non Recurring Items
-520.40M-647.30M-192.00M-273.00M-491.00M
Minority Interest Expense
473.10M-171.50M-60.00M0.00-43.00M
Cost Of Goods
2.37B2.11B1.80B1.96B1.82B
Gross Profit
8.00B8.87B11.64B12.42B11.64B
Operating Expenses
5.13B5.38B6.67B4.87B5.07B
Operating Income
2.86B3.50B4.97B7.56B6.57B
Interest Expense
1.08B-1.10B262.00M-105.00M-163.00M
Income Before Taxes
3.39B1.75B5.05B7.13B5.90B
Income Tax
1.02B52.50M992.00M1.16B1.40B
Net Income
2.86B1.56B4.00B5.89B4.43B
EBITDA
3.40B3.98B5.43B8.24B7.58B
 
Per Share Data
EPS Diluted Total Ops
19.6310.4024.8531.4921.61
Non GAAP EPS
17.7919.1832.8233.6426.24
 
Statistics
Gross Profit Margin
77.15%80.79%86.57%86.40%86.50%
Profit Margin
27.64%14.17%29.76%40.96%32.94%
Operating Profit Margin
27.64%31.83%37.00%52.57%48.80%

All data in USD

Charts